This document discusses metrics for measuring green chemistry performance in the pharmaceutical industry. It notes that pharmaceutical processes are complex, involving multiple reaction stages and waste streams. The author advocates asking the right questions to define appropriate metrics, as there are many options. Key lessons are that analysis provides value and positive change is possible through establishing the right process measures from early stages of development.
Here is a brief overview of some of my work at Mayo Clinic Jacksonville, where I worked in the Organic Synthesis Core Facility for the little over two years between my undergraduate education and graduate school.
The big topic of the last few years, the use of small organic molecules to catalyse enantioselective transformations. This lecture will start with proline before moving on to some of MacMillan's contributions to this field and, finally, finish with hydrogen bond catalysts and Brønsted acids.
Self explanatory really, this lecture looks at chiral auxiliaries. We will concentrate on oxazolidinones in alkylations, aldol reaction and the Diels-Alder reaction. There will be a couple examples of other auxiliaries.
Finishing oxidation by looking at the Baeyer-Villiger reaction and then turning our attention to reduction. Once again we will see the usual suspects with a who is who of hydride sources.
Here is a brief overview of some of my work at Mayo Clinic Jacksonville, where I worked in the Organic Synthesis Core Facility for the little over two years between my undergraduate education and graduate school.
The big topic of the last few years, the use of small organic molecules to catalyse enantioselective transformations. This lecture will start with proline before moving on to some of MacMillan's contributions to this field and, finally, finish with hydrogen bond catalysts and Brønsted acids.
Self explanatory really, this lecture looks at chiral auxiliaries. We will concentrate on oxazolidinones in alkylations, aldol reaction and the Diels-Alder reaction. There will be a couple examples of other auxiliaries.
Finishing oxidation by looking at the Baeyer-Villiger reaction and then turning our attention to reduction. Once again we will see the usual suspects with a who is who of hydride sources.
Hemicellulose extraction from wood OSB strandsroryjara
Extraction of wood components from OSB strands using hot water. A composition of the liquid phase (extract) is given for different extraction conditions. Mechanical properties of OSB panels made with the extracted wood are compared with standard panels.
Lecture 6: C-C bond formation
The big one; the all important formation of C-C bonds. Reagents include organometallics and enolates. There will also be a slight detour into the wonderful world of pKa.
Finishing off the reactions of carboxylic acid derivatives (well the substitution reactions) and introducing oxidation and reduction. Then looking at the oxidation of alkenes (epoxidation and dihydroxylation) and alcohols (the usual suspects).
Told you that this was the important one. This weeks reagents include more enolates and then reactions with the C=O group including the such classics as the Wittig reaction.
Hemicellulose extraction from wood OSB strandsroryjara
Extraction of wood components from OSB strands using hot water. A composition of the liquid phase (extract) is given for different extraction conditions. Mechanical properties of OSB panels made with the extracted wood are compared with standard panels.
Lecture 6: C-C bond formation
The big one; the all important formation of C-C bonds. Reagents include organometallics and enolates. There will also be a slight detour into the wonderful world of pKa.
Finishing off the reactions of carboxylic acid derivatives (well the substitution reactions) and introducing oxidation and reduction. Then looking at the oxidation of alkenes (epoxidation and dihydroxylation) and alcohols (the usual suspects).
Told you that this was the important one. This weeks reagents include more enolates and then reactions with the C=O group including the such classics as the Wittig reaction.
Discovery and development of 2,7-Disubstituted-Pyrrolo[2,1-f][1,2,4]triazines. A New Class of Anaplastic Lymphoma Kinase(ALK)*Inhibitors with in-vivo Anti-tumor Efficacy
Naked DNA And DNA Vaccines A Retrospectiverwmalonemd
A retrospective review starting from the genesis of genetic vaccination and naked gene delivery through development of cationic lipid and electroporative delivery of DNA (skin, muscle, liver, lung)
This is the biggy, the one everyone wants to achieve. Here we will be looking at metal-based chiral catalysis. We will concentrate on bisoxazoline-based Lewis acid catalysis and then look at reductions before finishing with the ubiquitous Sharpless epoxidation and dihydroxylation.
published in the journal Molecules, 2012-04; This review presents findings that indicate honey may improve oxidative stress in chronic diseases, such as in the gastrointestinal tract (GIT), liver,
pancreas, kidney, reproductive organs and plasma/serum.
A pharmaceutical Chemist shares a view of organic chemistry and his role preparing enantiomeric drugs for clinical trials. Dr. Welch is also on the Titan Explorer team looking for signs of life on other planets
Similar to Lessons learned - the pharma experience (20)
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navy’s DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATO’s (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
Removing Uninteresting Bytes in Software FuzzingAftab Hussain
Imagine a world where software fuzzing, the process of mutating bytes in test seeds to uncover hidden and erroneous program behaviors, becomes faster and more effective. A lot depends on the initial seeds, which can significantly dictate the trajectory of a fuzzing campaign, particularly in terms of how long it takes to uncover interesting behaviour in your code. We introduce DIAR, a technique designed to speedup fuzzing campaigns by pinpointing and eliminating those uninteresting bytes in the seeds. Picture this: instead of wasting valuable resources on meaningless mutations in large, bloated seeds, DIAR removes the unnecessary bytes, streamlining the entire process.
In this work, we equipped AFL, a popular fuzzer, with DIAR and examined two critical Linux libraries -- Libxml's xmllint, a tool for parsing xml documents, and Binutil's readelf, an essential debugging and security analysis command-line tool used to display detailed information about ELF (Executable and Linkable Format). Our preliminary results show that AFL+DIAR does not only discover new paths more quickly but also achieves higher coverage overall. This work thus showcases how starting with lean and optimized seeds can lead to faster, more comprehensive fuzzing campaigns -- and DIAR helps you find such seeds.
- These are slides of the talk given at IEEE International Conference on Software Testing Verification and Validation Workshop, ICSTW 2022.
Pushing the limits of ePRTC: 100ns holdover for 100 daysAdtran
At WSTS 2024, Alon Stern explored the topic of parametric holdover and explained how recent research findings can be implemented in real-world PNT networks to achieve 100 nanoseconds of accuracy for up to 100 days.
zkStudyClub - Reef: Fast Succinct Non-Interactive Zero-Knowledge Regex ProofsAlex Pruden
This paper presents Reef, a system for generating publicly verifiable succinct non-interactive zero-knowledge proofs that a committed document matches or does not match a regular expression. We describe applications such as proving the strength of passwords, the provenance of email despite redactions, the validity of oblivious DNS queries, and the existence of mutations in DNA. Reef supports the Perl Compatible Regular Expression syntax, including wildcards, alternation, ranges, capture groups, Kleene star, negations, and lookarounds. Reef introduces a new type of automata, Skipping Alternating Finite Automata (SAFA), that skips irrelevant parts of a document when producing proofs without undermining soundness, and instantiates SAFA with a lookup argument. Our experimental evaluation confirms that Reef can generate proofs for documents with 32M characters; the proofs are small and cheap to verify (under a second).
Paper: https://eprint.iacr.org/2023/1886
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024Neo4j
Neha Bajwa, Vice President of Product Marketing, Neo4j
Join us as we explore breakthrough innovations enabled by interconnected data and AI. Discover firsthand how organizations use relationships in data to uncover contextual insights and solve our most pressing challenges – from optimizing supply chains, detecting fraud, and improving customer experiences to accelerating drug discoveries.
Enchancing adoption of Open Source Libraries. A case study on Albumentations.AIVladimir Iglovikov, Ph.D.
Presented by Vladimir Iglovikov:
- https://www.linkedin.com/in/iglovikov/
- https://x.com/viglovikov
- https://www.instagram.com/ternaus/
This presentation delves into the journey of Albumentations.ai, a highly successful open-source library for data augmentation.
Created out of a necessity for superior performance in Kaggle competitions, Albumentations has grown to become a widely used tool among data scientists and machine learning practitioners.
This case study covers various aspects, including:
People: The contributors and community that have supported Albumentations.
Metrics: The success indicators such as downloads, daily active users, GitHub stars, and financial contributions.
Challenges: The hurdles in monetizing open-source projects and measuring user engagement.
Development Practices: Best practices for creating, maintaining, and scaling open-source libraries, including code hygiene, CI/CD, and fast iteration.
Community Building: Strategies for making adoption easy, iterating quickly, and fostering a vibrant, engaged community.
Marketing: Both online and offline marketing tactics, focusing on real, impactful interactions and collaborations.
Mental Health: Maintaining balance and not feeling pressured by user demands.
Key insights include the importance of automation, making the adoption process seamless, and leveraging offline interactions for marketing. The presentation also emphasizes the need for continuous small improvements and building a friendly, inclusive community that contributes to the project's growth.
Vladimir Iglovikov brings his extensive experience as a Kaggle Grandmaster, ex-Staff ML Engineer at Lyft, sharing valuable lessons and practical advice for anyone looking to enhance the adoption of their open-source projects.
Explore more about Albumentations and join the community at:
GitHub: https://github.com/albumentations-team/albumentations
Website: https://albumentations.ai/
LinkedIn: https://www.linkedin.com/company/100504475
Twitter: https://x.com/albumentations
GraphSummit Singapore | The Future of Agility: Supercharging Digital Transfor...Neo4j
Leonard Jayamohan, Partner & Generative AI Lead, Deloitte
This keynote will reveal how Deloitte leverages Neo4j’s graph power for groundbreaking digital twin solutions, achieving a staggering 100x performance boost. Discover the essential role knowledge graphs play in successful generative AI implementations. Plus, get an exclusive look at an innovative Neo4j + Generative AI solution Deloitte is developing in-house.
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!SOFTTECHHUB
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
In the rapidly evolving landscape of technologies, XML continues to play a vital role in structuring, storing, and transporting data across diverse systems. The recent advancements in artificial intelligence (AI) present new methodologies for enhancing XML development workflows, introducing efficiency, automation, and intelligent capabilities. This presentation will outline the scope and perspective of utilizing AI in XML development. The potential benefits and the possible pitfalls will be highlighted, providing a balanced view of the subject.
We will explore the capabilities of AI in understanding XML markup languages and autonomously creating structured XML content. Additionally, we will examine the capacity of AI to enrich plain text with appropriate XML markup. Practical examples and methodological guidelines will be provided to elucidate how AI can be effectively prompted to interpret and generate accurate XML markup.
Further emphasis will be placed on the role of AI in developing XSLT, or schemas such as XSD and Schematron. We will address the techniques and strategies adopted to create prompts for generating code, explaining code, or refactoring the code, and the results achieved.
The discussion will extend to how AI can be used to transform XML content. In particular, the focus will be on the use of AI XPath extension functions in XSLT, Schematron, Schematron Quick Fixes, or for XML content refactoring.
The presentation aims to deliver a comprehensive overview of AI usage in XML development, providing attendees with the necessary knowledge to make informed decisions. Whether you’re at the early stages of adopting AI or considering integrating it in advanced XML development, this presentation will cover all levels of expertise.
By highlighting the potential advantages and challenges of integrating AI with XML development tools and languages, the presentation seeks to inspire thoughtful conversation around the future of XML development. We’ll not only delve into the technical aspects of AI-powered XML development but also discuss practical implications and possible future directions.
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Threats to mobile devices are more prevalent and increasing in scope and complexity. Users of mobile devices desire to take full advantage of the features
available on those devices, but many of the features provide convenience and capability but sacrifice security. This best practices guide outlines steps the users can take to better protect personal devices and information.
National Security Agency - NSA mobile device best practices
Lessons learned - the pharma experience
1. Lessons learned through measuring
Green Chemistry performance:
The Pharmaceutical Experience
David J. C. Constable, PhD
Gaithersburg, MD 20878 DESCA - 2012
Telephone: 301-926-1402
e-mail: David.JC.Constable@gmail.com 5 March 2012
2. Carbon Efficiency
Reaction Mass Efficiency
Yield
Outline Atom
Economy
Stoichiometry
Mass Efficiency
First Challenges of the Pharma Context
Batch Chemical Operations
Second Metrics and Process
Ask the right questions
Total Water
Third Choose the Right Metrics
There are a lot of options
Fourth What did we Learn?
There is value in analysis
Total CO2
Fifth Conclusions
Positive change is possible Net Mass Excluding
Process Water
Energy
Solvent Recovery
Energy
3. The Pharmaceutical Industry is
Challenged by Complexity
O F OH
O HO O O
O S
H HO OH
O O O
O H NH N O O
N O O
H OH O H
OH O
F H N
O HO OH H
O
F HO
They are complex:
paclitaxel
F
fluticasone salmeterol atorvastatin
HN
• target molecules, reagents and reactants
• synthetic routes: 6+ stages
• processes and wastes: mixed aqueous and organic Cl
streams Cl
sertraline
Need for early and rapid definition of the synthetic route
But there is a high failure rate for target molecules
N O
N
N O N
O S N
N O
F H
N
O
esomeprazole
risperidone
4. The Pharmaceutical Industry
Regulatory Climate is Challenging
• Highly regulated by government agencies
• process changes
• use of recovered/recycled solvent
• Route and Process changes post-approval give the
appearance of being costly
• Regulatory / Legislative restrictions on solvent and
materials selection
• EU Solvent Directive, REACH, IPPC, ICH etc
5. Finding the Right Balance can be a
Challenge
Commercial
Focus on
Speed to
Market
Green process
Attrition
design early
when costs are lower
6. Green Chemistry and Metrics
WELCOME TO
Pine View, Colorado
Established 1872
“All he’s done is call it Green” Population 732
The person who sat behind me, GRC Green Elevation 5755
Chemistry Meeting, Oxford, 1999, as related by
John Hayler, GSK TOTAL 8359*
“If you don’t keep
score, you’re only practicing”
Jan Leshley, former CEO SB & GSK
*Audited by
3iDataCen
(Formerly, the Center
for
irrelevant, immaterial
and inconvenient
Data)
7. Key Message
Ask the right questions!
Avoid “the perfect uselessness of
knowing the answer to the wrong
question”
The Left Hand of Darkness
Ursula K. LeGuin
1969
9. Develop a process that fits in with
existing ways of working
Highlight key
sustainability issues for Complete at known stages
materials and process of development
Document PRMR Identify and
information communicate
opportunities
Vehicle for discussion with chemists, engineers and management
10. Green Metrics Template
Compound Number Benchmarking data against
Route Designation A3 projects in the same phase
Campaign # and Date CDD4
Intended Purpose of Campaign Ph II, POC work
Amount made 4.8kg Life cycle impact (FLASC) &
Date of Assessment and Reference 2-Aug-06
Solvent Acceptability Score
YOUR DATA
AVERAGE VALUES FOR CS-
FTIH PROJECTS
• f(mass, number, type of
Number of Stages 6 solvent)
Number of Chemistry Steps 7
Number of Stages Outsourced 3
Overall Yield % theoretical 37.3%
Mass Intensity kg/kg API 207.57 691
Priority materials of concern
Aqueous Mass Intensity* 86.76 flagged according to the GSK
Mass Productivity % 0.48% 0.29
Reaction Mass Efficiency % 8.57% 5.5 Chemicals Legislation Guide
Total Number of Solvents 10 8.8
Number of Solvents per Stage 2.33 2.4
e.g. for Compound X
Total Mass of Solvents / Kg API
195.9
(94% of reaction wt)
591 • Route A – none
Current Material Cost / Kg API
(from B+)
• Route B – Dichloromethane
FLASC Score (1-5) 1.9 1.4
• Route C – 1,4-dioxane
Solvent acceptability score (1-5)
• Route D – Dichloromethane
1.2 0.5
Materials of concern none
THF 30.2%
Methanol 15.75%
Major Contributors to Overall Mass
Toluene 12.5%
of Materials
Ethanol 10.9%
Additional Comments
11. Green Metrics Template Page 2
Mass Productivity benchmarked
against current GSK data by
phase of development
FLASC score for your project
measures the environmental
impact of materials in a route
benchmarked against GSK
processes
General guidance to help
interpret the metrics values and
sources of further information
12. FIND THE RIGHT METRICS
• Make objective comparisons
• Benchmark progress
• Drive change
• Demonstrate improvement
• Increase transparency
13. Principles of Green Chemistry and
Engineering – Simplified*
• Maximize resource efficiency
• Eliminate and minimize hazards and
pollution
• Design systems holistically and using
life cycle thinking
*See: Green Chemistry and Engineering: A Practical Design Approach.
Jimenez-Gonzalez C, Constable DJC. John Wiley and Sons. 2011, p 35- 37.
http://www.amazon.com/Green-Chemistry-Engineering-Practical-
Approach/dp/0470170875
14. Key Metrics are Essential
Can we change
the chemistry?
• Yield
Telescope, maximise
• Reaction Mass Efficiency (RME) convergency, pay
• No. of stages and no. of attention to order of
side chain coupling
chemistry steps
• Total no. of solvents and solvents Recycle/reuse 80 –
90 % of the mass!
per stage
• Mass Intensity and Mass Focus on
Productivity (Efficiency) optimising
use of a few
• Materials of Concern key materials
• Process life cycle environmental
impact Starting
Materials matter!
15. Reaction Mass Efficiency (RME)
RME = efficiency of conversion of
reactants into product. It includes:
Yield
Atom Economy
Stoichiometry of the reactants
16. Reaction Mass Efficiency
For a generic reaction:
A+B C
m.w.of product C
RME yield
m.w.of A (m.w.of B x molar ratio B/A)
or more simply:
mass of product C
RME X 100
mass of A mass of B
17. Top 10 Chemistries Used 2004 - 2005
N-acylation
11%
N-alkylations
8%
others
39%
recrystallisation
8%
salt formation/salt swap
6%
hydrolysis (base)
6%
OH activation/functional
group change
3% S-alkylation
6%
O-alkylation Chlorinations
3% 6%
hydrogenation
4%
18. Solvent Use in Pharma is Significant
• In 2008, 10 solvents
Water 32% Solvents 56%
represented approximately
80% of all solvents used in
GSK
Other 5%
• Solvent use is the largest
contributor to: Reactants 7%
• Primary manufacturing process
mass intensity Composition by mass of types of
material used to manufacture an API
• Primary manufacturing life American Chemical Society Green Chemistry Institute
Pharmaceutical Roundtable Benchmarking 2006 & 2008
cycle environmental impacts
(e.g., ~80% mass, ~75% energy)
19. Process Water 50
38.9
40
Average wt% water
32.5
28.6 29.7
30
20
10
0
CS to FTIH FTIH to PoC towards
PoC to CP III full Phase III
scale
Pre-clinical commercialisation
Data shows that the amount of process water used in washings and
extractions per kg API could be optimised further
20. used
0
5
10
15
20
25
E
th IP No of stages 30
A
Solvents
y la
ce
ta
M t e
et
ha
IM no
S/ l
E
th
a no
H l
ep
t an
e
TH
F
D To
ic
h lo
lu
e
ro ne
m
et
ha
A
Top 10 Most Frequently Used
ne
ce
tic
ac
A id
ce
to
ni
tri
le
21. mass, %
Et
hy
la
0
2
4
6
8
10
12
14
16
18
ce
ta 20
t e
IP
A
D
ic
h lo TH
ro F
m
et
ha
ne
M
et
ha
no
To l
l
IM uen
S/ e
Et
ha
Ac no
l
Top 10 Solvent Use by Mass
et
on
itr
ile
H
ep
ta
ne
Ac
et
on
e
22. Solvent Use % Solvent Mass
100
80
mass %
60 2005
40 2006
20
0
CS to FTIH FTIH to PoC PoC to CP III Phase III
towards full scale
Pre-clinical commercialisation
• Solvent mass is ~90 wt% of reaction mass excluding water
• Dilution of reactions is consistent across all phases of development
• The type of solvent used does change; e.g., the majority of
dichloromethane is removed by Proof of Concept
23. Mass Productivity Headline Data
2.5
< 50 kg
per kg API
Mass Productivity %
2.0
100 kg per kg
1.5 API
1.0
0.5
0.0
CS to FTIH FTIH to PoC towards full III
PoC to CP III Phase scale
Pre-clinical commercialisation
API = Active Pharmaceutical Ingredient
24. What does it take to achieve MP > 1?*
RME > 25% for MP > 1%
RME 15 – 25% yields a 40% probability of MP > 1%
Having < 4 stages increases probability for a MP > 1%
% probability of MP
stages
>1%
2 85
3 75
4 50
5 50
>6 15
*Based on about 40 mature R&D processes
25. Materials of Concern
Chemicals for which there is evidence of probable serious effects to
humans or the environment
• carcinogens, mutagens or reproductive hazards (CMR’s),
• toxic and bioaccumulate or persist in the environment (PBT’s),
• very persistent or very bioaccumulative in the environment (vPvB),
• ozone depleting chemicals (ODC’s),
• endocrine disruptors (ED’s)
• those known to cause asthma (asthmagens)
Materials of Concern should be identified early to
develop strategies to eliminate or substitute.
26. Materials of Concern in 2006
Average mass % of materials of concern in processes
25
99.4% solvents
98.7% solvents
20
% by mass
15
100% solvents
10
65% Solvents
5
0
CS to FTIH FTIH to POC POC to PhIII PhIII
towards full scale
Pre-clinical commercialisation
27. Materials of Concern 2006 – top 6
90 81% dichloromethane
80
70
Mass %
60
50
40
30
20
10
0
ne
e
ne
P
CM
F
in
M
M
ha
xa
rid
D
N
D
et
o
Py
Di
xy
4-
ho
1,
et
m
Di
2-
1,
Finding alternative solvents to replace dichloromethane remains a key green
chemistry challenge
28. Are pharmaceutical processes
becoming greener?
If solvent mass is ~ 90% of the reaction mass and ~ 75% of
the life cycle energy and mass, what about the other 10% of
the reaction mass?
Are there correlations with current measures of greenness?
Reaction Mass Efficiency vs.
GSK FLASC Score vs. Chemical Mass
Reaction Mass Efficiency vs. Molecular Weight Added
Mass Intensity per Chemistry Transformation
60
RME vs MI per Step CS to FTIH
GSK FLASC score vs Chemical Mass
FTIH to POC
60 50
5.0 CS to FTIH
PoC to PhIII
FTIH to POC
PhIII
4.5
GSK FLASC Score
50 40 PoC CS to FTIH
to FTIH
4.0 PhIII FTIH to POC
RME RME %
40
3.530
PoC to FTIH
PhIII
%
3.030
2.520
20
2.0
10
1.510
1.0 0
0
00 100 50 200 300 100 400 150
500 600 200
700
0 50 100 150 Added200
MW 250 300 350
Chemical Mass kg
MI per step kg
29. Average Non-Solvent Mass
250
200
Non Solvent Mass kg/kg API
150 Cs to FTIH
FTIH to POC
PoC to PhIII
100 PhIII
50
0
0 2 4 6 8 10 12
No of Stages
Optimization of reagent and reactant mass during development will
have the biggest impact for complex syntheses
30. Assessing over 100 pharmaceutical
processes tells us something important
• No correlation between non-solvent mass and
several different measures of greenness.
• Mass based metrics do not appear to account
for the complexity of the chemistry.
• Mass based metrics do not account for the
nature and impact of chemicals.
• Is there more we should be doing to
influence the selection of reagents to
reduce the impact of solvents?
31. Life Cycle Assessment – The very big
picture Raw material and energy consumption
R&D:
Process Development
Resource Raw Material Intermediate Products Final Product
Material Selection
Extraction Manufacture
Hazard & Risk assessment
Sales and
Marketing
Ultimate
Ecological
Fate
Store Distribution
Final Consumer Use
Emissions to air, water and land
32. Using a Streamlined Life Cycle Tool is Key
FLASCTM - Fast Lifecycle Assessment of
Synthetic Chemistry)
• Web-based tool and methodology
• Simple to use (but not simplistic)
• Determines and benchmarks the relative
sustainability of chemicals
• Based on cradle-to-gate LCA impacts
33. Life Cycle Impact - FLASC scores
65% of the Life FLASC - all data
Cycle impact of the 27% of the Life
average GSK
5.0 Cycle impact of the
process* average GSK
4.5
process*
4.0 3.9
3.5 3.5
FLASC
3.0 ave
2.8
2.5 37% of the Life
Cycle impact of the
2.0
1.9 average GSK
1.5 process*
130% of the Life
Cycle impact of the
1.0
average GSK CS to FTIH FTIH to PoC PoC to CP III Phase III full scale
towards
process* Pre-clinical commercialisation
The environmental life cycle impact of all new processes
post-PoC is potentially much lower than for current
processes in manufacturing
* 25 GSK routes developed during 1990 to 2000 were assessed.
The average performance was assigned a FLASC rating of 2.3
34. Life Cycle Impacts can be Decreased
FLASC and Solvent Acceptability score Few years ago:
histogram
Most FLASC and Solvent
50% Scores in lower range
40%
FLASC score (medians 2.4 & 2.2)
SAS score
30%
20%
10%
0%
<2.5 2 - 2.5 2.5 - 3 3 - 3.5 3.5 - 4 >4 FLASC and Solvent Acceptability score
histogram
50%
FLASC score
Now: 40% SAS score
Most FLASC and Solvent 30%
Scores in middle range
(medians 3.0 & 2.7) 20%
10%
0%
<2.5 2 - 2.5 2.5 - 3 3 - 3.5 3.5 - 4 >4
35. Conclusions
• Biggest impact from solvents: ~90 wt% of
reaction mass
• Effect on mass efficiency / intensity from
replacing and substituting hazardous with
non-hazardous chemicals is unknown
• GSK’s life cycle assessment metrics suggest
that processes in development are
potentially getting greener
36. Summary
• The Strategy is to regularly influence during
product development
• Green Metrics help Project Teams
• Green Metrics should include life cycle
assessment
• Metrics should be collected for every pilot plant
campaign
• Metrics alone do not tell the whole story
• Assessment of “greenness” is, and should be, a
multivariate exercise
37. Future Challenges
• Less toxic alternatives for hazardous solvents and
reagents
• Integration of chemistry and technology
• Application of continuous processing, novel reactors, solvent
systems
• Bioprocessing
• Further
development of tools to objectively compare
bioprocesses with chemical processes
• Greater attention to downstream processing issues
• Integration of life cycle considerations
• Renewable feedstocks.
• New, cleaner, reactions and methodology.
38. Acknowledgements
Concepción (Conchita) Jiménez-González
Richard Henderson
GSK’s Sustainable Processing Team:
• John Hayler
• Clare Ruddick
• Graham Geen
• Jonathan Emeigh
• Mario Almi
• Tom Roper
39. ACS Webinar March 8th
Measures of Green Chemistry Performance
http://acswebinars.org/constable
Any Questions?
Editor's Notes
Yield Reaction Mass Efficiency (RME)A measure of the chemistry efficiencyNo. of stages and no. of chemistry steps Measure of the route complexityTotal no. of solvents and solvents per stage solvent is the biggest influence on massMass Intensity and Mass Productivity (Efficiency)MI: total mass required to make 1 kg APIMP: total mass to make API ( %)Materials of ConcernEarly identification – materials matterProcess life cycle environmental impact: FLASC and Solvent Score